Wolfgang Löscher

Professor and Chair

University of Veterinary Medicine

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Collaborators (3)

Matthias Koepp

University College London

UNITED KINGDOM

Kai Kaila

University of Helsinki

Olaf van Tellingen

The Netherlands Cancer Institute

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wolfgang Löscher

Research Interests

Explore related searches

Contact this professor

Articles (17)

Collaborators (3)

Matthias Koepp

Kai Kaila

Olaf van Tellingen

Make your next move.

Wolfgang Löscher

Research Interests

Explore related searches

Contact this professor

Articles (17)

New epilepsy therapies in development

Tolerability of tariquidar – a third generation P-gp inhibitor as add-on medication to antiseizure medications in drug-resistant epilepsy

Mammalian models of status epilepticus – Their value and limitations

Heterogeneous brain distribution of bumetanide following systemic administration in rats

The impact of ATP-binding cassette transporters in the diseased brain: Context matters

Of Mice and Men: The Inter-individual Variability of the Brain's Response to Drugs

On hidden factors and design‐associated errors that may lead to data misinterpretation: An example from preclinical research on the potential seasonality of neonatal seizures

Effects of season, daytime, sex, and stress on the incidence, latency, frequency, severity, and duration of neonatal seizures in a rat model of birth asphyxia

Animal Models of Drug-Resistant Epilepsy as Tools for Deciphering the Cellular and Molecular Mechanisms of Pharmacoresistance and Discovering More Effective Treatments

Preclinical pharmacokinetics and tolerability of a novel meglumine‐based parenteral solution of topiramate and topiramate combinations for treatment of status epilepticus

Is the antiparasitic drug ivermectin a suitable candidate for the treatment of epilepsy?

Midazolam Prevents the Adverse Outcome of Neonatal Asphyxia

Epilepsy and its neurobehavioral comorbidities: Insights gained from animal models

Bumetanide for neonatal seizures: No light in the pharmacokinetic/dynamic tunnel

Is P-Glycoprotein Functionally Expressed in the Limiting Membrane of Endolysosomes? A Biochemical and Ultrastructural Study in the Rat Liver

Long‐term outcome in a noninvasive rat model of birth asphyxia with neonatal seizures: Cognitive impairment, anxiety, epilepsy, and structural brain alterations

The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond

Collaborators (3)

Matthias Koepp

Kai Kaila

Olaf van Tellingen

Make your next move.